CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Alpha (13335)
(-)
Architecture: Orthogonal Bundle (10391)
(-)
Topology: Cyclin A; domain 1 (136)
(-)
Homologous Superfamily: [code=1.10.472.10, no name defined] (99)
(-)
[unclassified] (5)
1AISB:1108-1206; B:1207-1300TATA-BINDING PROTEIN/TRANSCRIPTION FACTOR (II)B/TATA-BOX COMPLEX FROM PYROCOCCUS WOESEI
1C9BA:210-315; I:210-315; M:210-315; Q:210-315; A:113-209; E:113-209; I:113-209; M:113-209; Q:113-209; E:210-315CRYSTAL STRUCTURE OF A HUMAN TBP CORE DOMAIN-HUMAN TFIIB CORE DOMAIN COMPLEX BOUND TO AN EXTENDED, MODIFIED ADENOVIRAL MAJOR LATE PROMOTER (ADMLP)
1D3UB:1108-1206; B:1207-1300TATA-BINDING PROTEIN/TRANSCRIPTION FACTOR (II)B/BRE+TATA-BOX COMPLEX FROM PYROCOCCUS WOESEI
1GY3B:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE
1VOLA:210-315; A:113-209TFIIB (HUMAN CORE DOMAIN)/TBP (A.THALIANA)/TATA ELEMENT TERNARY COMPLEX
(-)
Cattle (Bos taurus) (1)
1VINA:181-194,A:308-432; A:195-307BOVINE CYCLIN A3
(-)
Herpesvirus saimiri (Saimiriine herpesvirus 2) (2)
1JOWA:37-148; A:149-254CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRAL CYCLIN
1XO2A:37-148; A:149-254CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR, FISETIN
(-)
Herpesvirus saimiri (strain 11). Organism_taxid: 10383. Strain: 11. (3)
1BU2A:37-148; A:149-250X-RAY STRUCTURE OF A VIRAL CYCLIN FROM HERPESVIRUS SAIMIRI
2EUFA:37-148; A:149-254X-RAY STRUCTURE OF HUMAN CDK6-VCYCLIN IN COMPLEX WITH THE INHIBITOR PD0332991
2F2CA:37-148; A:149-254X-RAY STRUCTURE OF HUMAN CDK6-VCYCLINWITH THE INHIBITOR AMINOPURVALANOL
(-)
Homo sapiens. Organism_taxid: 9606. (1)
3EOCB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE
(-)
Homo sapiens. Organism_taxid: 9606. (2)
2WMAB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
2WMBB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
(-)
Human (Homo sapiens) (84)
1AD6A:378-562DOMAIN A OF HUMAN RETINOBLASTOMA TUMOR SUPPRESSOR
1E9HB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
1F5QB:6-36,B:146-252; D:6-36,D:146-252; B:37-145; D:37-145CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2
1FINB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
1FVVB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
1G3NC:16-34,C:148-253; G:16-34,G:148-252; C:35-147; G:35-147STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX
1GUXB:645-785; A:380-577RB POCKET BOUND TO E7 LXCXE MOTIF
1H1PB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
1H1QB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
1H1RB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
1H1SB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
1H24B:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
1H25B:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
1H26B:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
1H27B:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
1H28B:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
1H4LD:147-293; E:147-293STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
1JKWA:161-261; A:11-160,A:262-287STRUCTURE OF CYCLIN MCS2
1JSTB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
1JSUB:181-194,B:308-432; B:195-307P27(KIP1)/CYCLIN A/CDK2 COMPLEX
1KXUA:161-261; A:11-160,A:262-286CYCLIN H, A POSITIVE REGULATORY SUBUNIT OF CDK ACTIVATING KINASE
1N4MA:564-785; B:564-785; B:380-563; A:380-563STRUCTURE OF RB TUMOR SUPPRESSOR BOUND TO THE TRANSACTIVATION DOMAIN OF E2F-2
1O9KB:644-787; D:644-787; F:644-787; H:644-787; A:379-578; C:379-578; E:379-578; G:379-578CRYSTAL STRUCTURE OF THE RETINOBLASTOMA TUMOUR SUPPRESSOR PROTEIN BOUND TO E2F PEPTIDE
1OGUB:181-194,B:308-431; D:195-307; B:195-307; D:181-194,D:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
1OI9D:181-194,D:308-430; B:195-307; D:195-307; B:181-194,B:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIUB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIYB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OKVB:181-194,B:308-431; B:195-307; D:195-307; D:181-194,D:308-432CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
1OKWB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
1OL1B:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
1OL2B:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
1P5EB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS)
1PKDB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A
1QMZB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
1TFBA:208-316; A:113-207NMR STUDIES OF HUMAN GENERAL TRANSCRIPTION FACTOR TFIIB: DYNAMICS AND INTERACTION WITH VP16 ACTIVATION DOMAIN, 20 STRUCTURES
1UNGE:147-294; D:145-294STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNHD:147-294; E:147-294STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNLD:145-294; E:145-294STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.
1URCB:181-194,B:308-431; B:195-307; D:195-307; D:181-194,D:308-432CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
1VYWB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
1W98B:114-227; B:97-113,B:228-357THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
2B9RA:23-134; B:23-134CRYSTAL STRUCTURE OF HUMAN CYCLIN B1
2BKZB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2BPMB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
2C4GB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2C5NB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5OB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5VB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5XB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C6TB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2CCHD:181-194,D:308-431; B:181-194,B:308-432; B:195-307; D:195-307THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE
2CCIB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2CJMB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
2G9XB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2I40B:181-194,B:308-431; D:181-194,D:308-432; B:195-307; D:195-307CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
2IW6B:181-194,B:308-431; B:195-307; D:195-307; D:181-194,D:308-431STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2IW8B:181-194,B:308-431; D:195-307; B:195-307; D:181-194,D:308-431STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2IW9B:181-194,B:308-431; D:195-307; B:195-307; D:181-194,D:308-431STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2JGZB:187-298CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
2PHGA:208-316; A:113-207MODEL FOR VP16 BINDING TO TFIIB
2R7GA:564-785; C:564-785; A:380-563; C:380-563STRUCTURE OF THE RETINOBLASTOMA PROTEIN POCKET DOMAIN IN COMPLEX WITH ADENOVIRUS E1A CR1 DOMAIN
2UUEB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2UZBB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZDB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZEB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZLB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V22B:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2WEVB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WFYB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WHBB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WIHD:181-194,D:308-432; B:195-307; D:195-307; B:181-194,B:308-432STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2WIPB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID
2WPAB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2WXVB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2X1NB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3BHTB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
3BHUB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
3BHVB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
3DDPB:181-194,B:308-432; D:181-194,D:308-438; B:195-307; D:195-307STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
3DDQB:181-194,B:308-432; D:181-194,D:308-439; B:195-307; D:195-307STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
3DOGB:181-194,B:308-432; D:181-194,D:308-434; B:195-307; D:195-307STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
3EIDB:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3EJ1B:181-194,B:308-432; D:181-194,D:308-432; B:195-307; D:195-307CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3F5XB:181-194,B:308-432; B:195-307; D:195-307; D:181-194,D:308-432CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
(-)
Simian virus 40. Organism_taxid: 10633. (1)
1GH6B:564-772; B:380-563RETINOBLASTOMA POCKET COMPLEXED WITH SV40 LARGE T ANTIGEN
(-)
Homologous Superfamily: [code=1.10.472.20, no name defined] (29)
(-)
Bacillus smithii. Organism_taxid: 1479. (1)
1V29B:1-132CRYSTAL STRUCTURE OF NITRILE HYDRATASE FROM A THERMOPHILE BACILLUS SMITHII
(-)
Geobacillus pallidus. Organism_taxid: 33936. Strain: rapc8. (1)
3HHTB:1-132A MUTANT OF THE NITRILE HYDRATASE FROM GEOBACILLUS PALLIDUS HAVING ENHANCED THERMOSTABILITY
(-)
Pseudonocardia thermophila. Organism_taxid: 1848. (1)
1IREB:1-126CRYSTAL STRUCTURE OF CO-TYPE NITRILE HYDRATASE FROM PSEUDONOCARDIA THERMOPHILA
(-)
Pseudonocardia thermophila. Organism_taxid: 1848. Strain: jcm 3095. (4)
1UGPB:1-126CRYSTAL STRUCTURE OF CO-TYPE NITRILE HYDRATASE COMPLEXED WITH N-BUTYRIC ACID
1UGQB:1-126CRYSTAL STRUCTURE OF APOENZYME OF CO-TYPE NITRILE HYDRATASE
1UGRB:1-126CRYSTAL STRUCTURE OF AT109S MUTANT OF CO-TYPE NITRILE HYDRATASE
1UGSB:1-126CRYSTAL STRUCTURE OF AY114T MUTANT OF CO-TYPE NITRILE HYDRATASE
(-)
R312 (Rhodococcus sp) (1)
1AHJB:1-110; D:1-110; F:1-110; H:1-110NITRILE HYDRATASE
(-)
Rapc8 (Bacillus sp) (1)
2DPPB:1-132CRYSTAL STRUCTURE OF THERMOSTABLE BACILLUS SP. RAPC8 NITRILE HYDRATASE
(-)
Rhodococcus erythropolis. Organism_taxid: 1833. (1)
2ZCFB:1-110MUTATIONAL STUDY ON ALPHA-GLN90 OF FE-TYPE NITRILE HYDRATASE FROM RHODOCOCCUS SP. N771
(-)
Rhodococcus erythropolis. Organism_taxid: 1833. Strain: n-771. (5)
3A8GB:1-110CRYSTAL STRUCTURE OF NITRILE HYDRATASE MUTANT S113A COMPLEXED WITH TRIMETHYLACETONITRILE
3A8HB:1-110CRYSTAL STRUCTURE OF NITRILE HYDRATASE MUTANT S113A COMPLEXED WITH TRIMETHYLACETAMIDE
3A8LB:1-110CRYSTAL STRUCTURE OF PHOTO-ACTIVATION STATE OF NITRILE HYDRATASE MUTANT S113A
3A8MB:1-110CRYSTAL STRUCTURE OF NITRILE HYDRATASE MUTANT Y72F COMPLEXED WITH TRIMETHYLACETONITRILE
3A8OB:1-110CRYSTAL STRUCTURE OF NITRILE HYDRATASE COMPLEXED WITH TRIMETHYLACETAMIDE
(-)
Rhodococcus erythropolis. Organism_taxid: 1833. Strain: n771. (12)
2CYZB:1-110PHOTO-ACTIVATION STATE OF FE-TYPE NHASE IN ANAEROBIC CONDITION
2CZ0B:1-110PHOTO-ACTIVATION STATE OF FE-TYPE NHASE IN AEROBIC CONDITION
2CZ1B:1-110PHOTO-ACTIVATION STATE OF FE-TYPE NHASE WITH N-BA IN ANAEROBIC CONDITION
2CZ6B:1-110COMPLEX OF INACTIVE FE-TYPE NHASE WITH CYCLOHEXYL ISOCYANIDE
2CZ7B:1-110FE-TYPE NHASE PHOTO-ACTIVATED FOR 75MIN AT 105K
2D0QB:1-110COMPLEX OF FE-TYPE NHASE WITH CYCLOHEXYL ISOCYANIDE, PHOTO-ACTIVATED FOR 1HR AT 277K
2ZPBB:1-110NITROSYLATED FE-TYPE NITRILE HYDRATASE
2ZPEB:1-110NITROSYLATED FE-TYPE NITRILE HYDRATASE WITH TERT-BUTYLISONITRILE
2ZPFB:1-110COMPLEX OF FE-TYPE NITRILE HYDRATASE WITH TERT-BUTYLISONITRILE, PHOTO-ACTIVATED FOR 18MIN AT 293K
2ZPGB:1-110COMPLEX OF FE-TYPE NITRILE HYDRATASE WITH TERT-BUTYLISONITRILE, PHOTO-ACTIVATED FOR 120MIN AT 293K
2ZPHB:1-110COMPLEX OF FE-TYPE NITRILE HYDRATASE WITH TERT-BUTYLISONITRILE, PHOTO-ACTIVATED FOR 340MIN AT 293K
2ZPIB:1-110COMPLEX OF FE-TYPE NITRILE HYDRATASE WITH TERT-BUTYLISONITRILE, PHOTO-ACTIVATED FOR 440MIN AT 293K
(-)
Rhodococcus erythropolis. Organism_taxid: 1833. Strain: sp. N-771. (1)
2AHJB:1-110; D:1-110NITRILE HYDRATASE COMPLEXED WITH NITRIC OXIDE
(-)
Rhodococcus erythropolis. Strain: aj270. (1)
2QDYB:1-110CRYSTAL STRUCTURE OF FE-TYPE NHASE FROM RHODOCOCCUS ERYTHROPOLIS AJ270
(-)
Homologous Superfamily: HD-domain/PDEase-like (5)
(-)
Bacillus halodurans. Strain: c-125. (1)
3DTOA:2-100; B:2-100; C:2-100; D:2-100CRYSTAL STRUCTURE OF THE METAL-DEPENDENT HD DOMAIN-CONTAINING HYDROLASE BH2835 FROM BACILLUS HALODURANS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BHR130.
(-)
Bacillus thuringiensis serovar konkukian. Organism_taxid: 180856. Strain: 97-27. (1)
3DJBA:2-99; B:2-99CRYSTAL STRUCTURE OF A HD-SUPERFAMILY HYDROLASE (BT9727_1981) FROM BACILLUS THURINGIENSIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BUR114
(-)
Lactobacillus plantarum wcfs1. Organism_taxid: 220668. Strain: wcfs1,ncimb 8826. (1)
2PJQA:2-99; D:2-99; B:2-99; C:2-99CRYSTAL STRUCTURE OF Q88U62_LACPL FROM LACTOBACILLUS PLANTARUM. NORTHEAST STRUCTURAL GENOMICS TARGET LPR71
(-)
Listeria innocua clip11262. Organism_taxid: 272626. Strain: clip11262/ serovar 6a. (1)
3B57A:2-100CRYSTAL STRUCTURE OF THE LIN1889 PROTEIN (Q92AN1) FROM LISTERIA INNOCUA. NORTHEAST STRUCTURAL CONSORTIUM TARGET LKR65
(-)
Staphylococcus epidermidis atcc 12228. Organism_taxid: 176280. Strain:atcc 12228. (1)
2QGSB:2-99; A:2-101CRYSTAL STRUCTURE OF SE1688 PROTEIN FROM STAPHYLOCOCCUS EPIDERMIDIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SER89
(-)
Homologous Superfamily: Hypothetical protein mg237 homolog; domain 3 (1)
(-)
Mycoplasma pneumoniae. Organism_taxid: 2104. (1)
1TD6A:199-290CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN MP506/MPN330 (GI: 1674200)FROM MYCOPLASMA PNEUMONIAE
(-)
Homologous Superfamily: putative protein disulfide isomerase domain (1)
(-)
Nitrosomonas europaea. Organism_taxid: 915. (1)
2IN3A:50-172CRYSTAL STRUCTURE OF A PUTATIVE PROTEIN DISULFIDE ISOMERASE FROM NITROSOMONAS EUROPAEA
(-)
Homologous Superfamily: Transcription elongatin factor s-ii. (1)
(-)
Baker's yeast (Saccharomyces cerevisiae) (1)
1ENWA:1-114ELONGATION FACTOR TFIIS DOMAIN II